SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001104659-22-114953
Filing Date
2022-11-04
Accepted
2022-11-04 17:00:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM F-1/A tm2227759d2_f1a.htm F-1/A 553360
2 EXHIBIT 23.1 tm2227759d2_ex23-1.htm EX-23.1 3825
  Complete submission text file 0001104659-22-114953.txt   558352
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-1/A | Act: 33 | File No.: 333-267840 | Film No.: 221362968
SIC: 2834 Pharmaceutical Preparations